Market Cap 2.80B
Revenue (ttm) 445.76M
Net Income (ttm) 24.14M
EPS (ttm) N/A
PE Ratio 37.77
Forward PE 39.38
Profit Margin 5.42%
Debt to Equity Ratio 0.00
Volume 497,500
Avg Vol 913,514
Day's Range N/A - N/A
Shares Out 78.67M
Stochastic %K 91%
Beta 2.11
Analysts Strong Sell
Price Target $40.67

Company Profile

Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It is also developing the nCounter analysis system services. The company...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 650 243 6300
Fax: 650 243 6388
Address:
6000 Shoreline Court, Suite 300, South San Francisco, United States
Following_the_trend
Following_the_trend Oct. 22 at 6:43 PM
$VCYT small add today
0 · Reply
PhishTourFunds
PhishTourFunds Oct. 21 at 3:12 AM
1 · Reply
JarvisFlow
JarvisFlow Oct. 20 at 10:46 AM
Canaccord Genuity has adjusted their stance on Veracyte ( $VCYT ), setting the rating to Hold with a target price of 40.
0 · Reply
JarvisFlow
JarvisFlow Oct. 17 at 12:23 PM
Freedom Capital Markets updates rating for Veracyte ( $VCYT ) to Buy, target set at 45.
0 · Reply
PhishTourFunds
PhishTourFunds Oct. 17 at 1:34 AM
$VCYT Dead board, original play from late July 50% gainer and holding steady
0 · Reply
RunnerSignals
RunnerSignals Oct. 16 at 5:22 PM
Fresh highs for $MS $TJX $HCI while $VCYT crosses key MA and $NOMD oversold https://stocksrunner.com/news/2025-10-16-intraday-technical-patterns-show-mixed-signals
0 · Reply
PhishTourFunds
PhishTourFunds Oct. 6 at 7:06 AM
$VCYT $35 target acquired from $23
0 · Reply
SilverEagle
SilverEagle Oct. 3 at 5:37 PM
$VCYT ride that ema into year end.
0 · Reply
PhishTourFunds
PhishTourFunds Oct. 1 at 3:51 AM
$VCYT Exclusive play and $35 almost touched twice now
0 · Reply
G101SPM
G101SPM Sep. 29 at 9:47 AM
$VCYT $33.44 HOLDING LONG POSITON. BRIEF: Company announced new data from the prospective, randomized integral biomarker BALANCE trial (NCT03371719) finds that the PAM50 molecular signature predicts which patients with recurrent prostate cancer benefit from hormone therapy with apalutamide in addition to salvage radiation therapy. The prostate PAM50 biomarker is currently available for Research Use Only on the Decipher GRID (Genomic Resource for Intelligent Discovery) research tool.
0 · Reply
Latest News on VCYT
Veracyte: Q2 Earnings Brings My Position Out Of Mothballs

Aug 26, 2025, 10:18 AM EDT - 2 months ago

Veracyte: Q2 Earnings Brings My Position Out Of Mothballs


Veracyte, Inc. (VCYT) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 2:20 AM EDT - 2 months ago

Veracyte, Inc. (VCYT) Q2 2025 Earnings Call Transcript


Veracyte Announces Second Quarter 2025 Financial Results

Aug 6, 2025, 4:05 PM EDT - 2 months ago

Veracyte Announces Second Quarter 2025 Financial Results


Veracyte to Participate in Upcoming Investor Conferences

May 20, 2025, 5:00 PM EDT - 5 months ago

Veracyte to Participate in Upcoming Investor Conferences


Veracyte, Inc. (VCYT) Q1 2025 Earnings Call Transcript

May 8, 2025, 12:49 AM EDT - 6 months ago

Veracyte, Inc. (VCYT) Q1 2025 Earnings Call Transcript


Veracyte Announces First Quarter 2025 Financial Results

May 7, 2025, 4:05 PM EDT - 6 months ago

Veracyte Announces First Quarter 2025 Financial Results


Solid Growth, Soft Outlook: Why I'm Holding On Veracyte

Feb 25, 2025, 10:32 AM EST - 8 months ago

Solid Growth, Soft Outlook: Why I'm Holding On Veracyte


Veracyte, Inc. (VCYT) Q4 2024 Earnings Call Transcript

Feb 24, 2025, 10:53 PM EST - 8 months ago

Veracyte, Inc. (VCYT) Q4 2024 Earnings Call Transcript


Veracyte, Inc. (VCYT) Q3 2024 Earnings Call Transcript

Nov 6, 2024, 10:49 PM EST - 1 year ago

Veracyte, Inc. (VCYT) Q3 2024 Earnings Call Transcript


Veracyte Announces Third Quarter 2024 Financial Results

Nov 6, 2024, 4:05 PM EST - 1 year ago

Veracyte Announces Third Quarter 2024 Financial Results


Veracyte, Inc. (VCYT) Q2 2024 Earnings Call Transcript

Aug 6, 2024, 10:17 PM EDT - 1 year ago

Veracyte, Inc. (VCYT) Q2 2024 Earnings Call Transcript


Veracyte Announces Second Quarter 2024 Financial Results

Aug 6, 2024, 4:05 PM EDT - 1 year ago

Veracyte Announces Second Quarter 2024 Financial Results


Veracyte Announces First Quarter 2024 Financial Results

May 7, 2024, 4:05 PM EDT - 1 year ago

Veracyte Announces First Quarter 2024 Financial Results


Following_the_trend
Following_the_trend Oct. 22 at 6:43 PM
$VCYT small add today
0 · Reply
PhishTourFunds
PhishTourFunds Oct. 21 at 3:12 AM
1 · Reply
JarvisFlow
JarvisFlow Oct. 20 at 10:46 AM
Canaccord Genuity has adjusted their stance on Veracyte ( $VCYT ), setting the rating to Hold with a target price of 40.
0 · Reply
JarvisFlow
JarvisFlow Oct. 17 at 12:23 PM
Freedom Capital Markets updates rating for Veracyte ( $VCYT ) to Buy, target set at 45.
0 · Reply
PhishTourFunds
PhishTourFunds Oct. 17 at 1:34 AM
$VCYT Dead board, original play from late July 50% gainer and holding steady
0 · Reply
RunnerSignals
RunnerSignals Oct. 16 at 5:22 PM
Fresh highs for $MS $TJX $HCI while $VCYT crosses key MA and $NOMD oversold https://stocksrunner.com/news/2025-10-16-intraday-technical-patterns-show-mixed-signals
0 · Reply
PhishTourFunds
PhishTourFunds Oct. 6 at 7:06 AM
$VCYT $35 target acquired from $23
0 · Reply
SilverEagle
SilverEagle Oct. 3 at 5:37 PM
$VCYT ride that ema into year end.
0 · Reply
PhishTourFunds
PhishTourFunds Oct. 1 at 3:51 AM
$VCYT Exclusive play and $35 almost touched twice now
0 · Reply
G101SPM
G101SPM Sep. 29 at 9:47 AM
$VCYT $33.44 HOLDING LONG POSITON. BRIEF: Company announced new data from the prospective, randomized integral biomarker BALANCE trial (NCT03371719) finds that the PAM50 molecular signature predicts which patients with recurrent prostate cancer benefit from hormone therapy with apalutamide in addition to salvage radiation therapy. The prostate PAM50 biomarker is currently available for Research Use Only on the Decipher GRID (Genomic Resource for Intelligent Discovery) research tool.
0 · Reply
AlertsAndNews
AlertsAndNews Sep. 28 at 10:15 PM
$VCYT Veracyte Announces that Decipher-Enabled Biomarker Predicts Hormone Therapy Benefit in Men with Recurrent Prostate Cancer New data from the randomized BALANCE trial (NCT03371719) demonstrated that the PAM50 molecular signature can identify which recurrent prostate cancer patients benefit from adding apalutamide to salvage radiation therapy.
0 · Reply
AttractDontChase
AttractDontChase Sep. 27 at 3:39 AM
IVDA the next life changing small cap run, is on the horizon. IVDA might be the only true AI + drone stock trading this low. Real defense tech. Real installations. Smart surveillance + threat detection is a trillion-dollar theme and this is how you get in early.! $TALK $LVLU $MLGO $CRVS $VCYT
0 · Reply
thecontracap
thecontracap Sep. 22 at 3:25 PM
$MDXH 3.5x rev is $8. $4X rev is $9.50. $VCYT grows half as fast and trades 4.5x.
1 · Reply
PhishTourFunds
PhishTourFunds Sep. 20 at 11:33 PM
$VCYT $35 almost reached 🎯
0 · Reply
SilverEagle
SilverEagle Sep. 19 at 1:20 PM
$VCYT busting through. Let’s get weekly closes > 35
1 · Reply
PhishTourFunds
PhishTourFunds Sep. 5 at 3:13 PM
0 · Reply
NVDAMillionaire
NVDAMillionaire Sep. 4 at 7:53 AM
$VCYT Great piece that accurately captures VCYT's current position. So if you want to refresh your understanding of VCYT or learn about VCYT for the first time, this is essential reading. https://beyondspx.com/quote/VCYT/veracyte-genomic-diagnostics-powerhouse-forging-a-path-to-sustained-profitability-nasdaq-vcyt#analysis
0 · Reply
PhishTourFunds
PhishTourFunds Aug. 23 at 1:59 PM
0 · Reply
PhishTourFunds
PhishTourFunds Aug. 19 at 1:26 AM
$VCYT I dream about setups like that…
0 · Reply
ManosDeDiamante07
ManosDeDiamante07 Aug. 18 at 2:57 PM
$VCYT Killing the game 😎💰
0 · Reply
DonZulu
DonZulu Aug. 14 at 4:28 AM
$VCYT oh shit how did i miss this last week
1 · Reply
PhishTourFunds
PhishTourFunds Aug. 13 at 8:37 PM
$VCYT That was the only order that filled unfortunately…stock now sitting over $30 🔥
1 · Reply